<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-94773</identifier>
<setSpec>0210-0010</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Atributos psicométricos de la scales for outcomes in Parkinson´s disease-psychosocial (SCOPA-PS): Validación en españa y Revisión</dc:title>
<dc:description xml:lang="en">Summary. Aims. To evaluate the psychometric attributes of the Scales for Outcomes in Parkinson&#146;s Disease-Psychosocial (SCOPA-PS) in Spain and to compare them with previous studies. Patients and methods. We performed a multi-centre, crosssectional study of 387 patients with Parkinson&#146;s disease (PD), 70% of whom were in Hoehn and Yahr (HY) stages 2 or 3, with a mean age of 65.8 ± 11.1 years and 8.1 ± 6 years&#146;progression. The following measures were applied: SCOPA-Motor, SCOPACognition, modified Parkinson&#146;s Psychosis Rating Scale, Clinical Impression of Severity Index for Parkinson&#146;s Disease (CISIPD),  Cumulative Illness Rating Scale-Geriatrics, SCOPA-Autonomic, SCOPA-Sleep, Hospital Anxiety and Depression Scale (HADS), Fatigue and Pain Visual Analogue Scales, EQ-5D and SCOPA-PS. Acceptability, internal consistence, dimensionality, construct validity and precision of the SCOPA-PS were analysed. Results. The SCOPA-PS summary index displayed no ceiling or floor effect. Internal consistence was satisfactory (alpha = 0.85; item-total correlation =&gt; 0.39). Two factors were identified  (53.5% of the variance). The SCOPA-PS was highly correlated (rS =&gt; 0.5) with the HADS, SCOPA-Motor, SCOPA-Automatic and EQ-5D index, and moderately so (rS = 0.35-0.49) with CISI-PD, fatigue and HY. The SCOPA-PS discriminated significantly between patients grouped according to HY stages, levels of severity of the CISI-PD, age groups and length of time with PD. The standard error of the measure was 7.24 ± 18.7. As a whole, these findings are in agreement with previous studies. Conclusions. The SCOPA-PS is a scale with a satisfactory degree of acceptability, and it is consistent, valid and precise for  evaluating the psychosocial impact of PD (AU)</dc:description>
<dc:creator>de Pedro Cuesta, J</dc:creator>
<dc:creator>Forjaz, M. J</dc:creator>
<dc:creator>Frandes Payo, B</dc:creator>
<dc:creator>Carroza García, E</dc:creator>
<dc:creator>Rodríguez Blázquez, C</dc:creator>
<dc:creator>Martínez Martín, P</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Resumen. Objetivos. Evaluar los atributos psicométricos de la Scales for Outcomes in Parkinson&#146;s Disease-Psychosocial (SCOPA-PS) en España, y compararlos con los estudios previos. Pacientes y métodos. Estudio multicéntrico y transversal sobre 387 pacientes con enfermedad de Parkinson (EP), el 70% en estadios Hoehn y Yahr (HY) 2 o 3, con edad media 65,8 ± 11,1 años y 8,1 ± 6 años de evoluación. Se aplicaron las siguientes medidas: SCOPA-Motor, SCOPA-Cognición, Parkinson&#146;s Psychosis Rating Scale modificada, índice de impresión clínica de gravedad (CISI-PD), Cumulative Illness Rating Scale- Geriatrics, SCOPA-Autonómica, SCOPA-Sueño, escala hospitalaria de ansiedad y depresión (HADS), escalas visuales analógicas de dolor y fatiga, EQ-5D y SCOPA-PS. Se analizaron la aceptabilidad, consistencia interna, dimensionalidad, validez de constructo y precisión de la SCOPA-PS. Resultados. El índice sumarial de la SCOPA-PS no mostró efecto suelo o techo. La  consistencia interna fue satisfactoria (alfa = 0,85; correlación ítem-total =&gt; 0,39). Se identificaron dos factores (un 53,5% de la varianza). La SCOPA-PS mostró una alta correlación (rS =&gt; 0,50) con el índice EQ-5D, HADS, SCOPA-Motor y SCOPAAutonómica, y moderada (rS = 0,35-0,49) con CISI-PD, fatiga y HY. La SCOPA-PS discriminó significativamente entre pacientes agrupados por estadios HY, niveles de gravedad del CISI-PD, grupos de edad y de duración de la EP. El error estándar de la medida resultó 7,24 ± 18,7. En conjunto, estos hallazgos concuerdan con estudios previos. Conclusión. La SCOPAPS  es una escala con aceptabilidad satisfactoria, consistente, válida y precisa para evaluar el impacto psicosocial de la EP (AU)</dc:description>
<dc:source>Rev Neurol;49(1): 1-7, jul. 2009. tab</dc:source>
<dc:identifier>ibc-94773</dc:identifier>
<dc:title xml:lang="es">Atributos psicométricos de la Scales for Outcomes in Parkinson&#146;s Disease-Psychosocial (SCOPA-PS): validación en España y revisión</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d12031^s22039</dc:subject>
<dc:subject>^d1012^s22080</dc:subject>
<dc:subject>^d13275^s22080</dc:subject>
<dc:subject>^d12006</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3883^s22080</dc:subject>
<dc:subject>^d10489^s22056</dc:subject>
<dc:subject>^d10333^s22080</dc:subject>
<dc:subject>^d5325^s22080</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:type>article</dc:type>
<dc:date>200907</dc:date>
</metadata>
</record>
</ibecs-document>
